Hangzhou Bio-Sincerity Pharma-Tech's Controlling Shareholders Terminate Change-Of-Control Plans
Hangzhou Bio-Sincerity Pharma-Tech's (SHE:301096) controlling shareholders agreed to terminate the proposal to change the company's control, according to a Shenzhen bourse filing on Monday.The decision was made with related parties due to the complexity of the matter.The drug research and development company's shares slumped by less than 10% at the close.